Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 234

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation

Open access
Pasch, Cheri A., Favreau, Peter F., Yueh, Alexander E., Babiarz, Christopher P., Gillette, Amani A., Sharick, Joe T., Karim, Mohammad Rezaul, Nickel, Kwangok P., DeZeeuw, Alyssa K., Sprackling, Carley M., Emmerich, Philip B., DeStefanis, Rebecca A., Pitera, Rosabella T., Payne, Susan N., Korkos, Demetra P., Clipson, Linda, Walsh, Christine M., Miller, Devon, Carchman, Evie H., Burkard, Mark E., Lemmon, Kayla K., Matkowskyj, Kristina A., Newton, Michael A., Ong, Irene M., Bassetti, Michael F., Kimple, Randall J., Skala, Melissa C., Deming, Dustin A. · 2019 · Clinical Cancer Research

Abstract

Purpose: Cancer treatment is limited by inaccurate predictors of patient-specific therapeutic response. Therefore, some patients are exposed to unnecessary side effects and delays in starting effective therapy. A clinical tool that predicts treatment sensitivity for individual patients is needed. Experimental Design: Patient-derived cancer organoids were derived across multiple histologies. The histologic characteristics, mutation profile, clonal structure, and response to chemotherapy and radiation were assessed using bright-field and optical metabolic imaging on spheroid and single-cell levels, respectively. Results: We demonstrate that patient-derived cancer organoids represent the cancers from which they were derived, including key histologic and molecular features. These cultures were generated from numerous cancers, various biopsy sample types, and in different clinical settings. Next-generation sequencing reveals the presence of subclonal populations within the organoid cultures. These cultures allow for the detection of clonal heterogeneity with a greater sensitivity than bulk tumor sequencing. Optical metabolic imaging of these organoids provides cell-level quantification of treatment response and tumor heterogeneity allowing for resolution of therapeutic differences between patient samples. Using this technology, we prospectively predict treatment response for a patient with metastatic colorectal cancer. Conclusions: These studies add to the literature demonstrating feasibility to grow clinical patient-derived organotypic cultures for treatment effectiveness testing. Together, these culture methods and response assessment techniques hold great promise to predict treatment sensitivity for patients with cancer undergoing chemotherapy and/or radiation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-18-3590

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 234

Metadata

Authors
Pasch, C. A., Favreau, P. F., Yueh, A. E., Babiarz, C. P., Gillette, A. A., Sharick, J. T., Karim, M. R., Nickel, K. P., DeZeeuw, A. K., Sprackling, C. M., Emmerich, P. B., DeStefanis, R. A., Pitera, R. T., Payne, S. N., Korkos, D. P., Clipson, L., Walsh, C. M., Miller, D., Carchman, E. H., Burkard, M. E., Lemmon, K. K., Matkowskyj, K. A., Newton, M. A., Ong, I. M., Bassetti, M. F., Kimple, R. J., Skala, M. C., & Deming, D. A.
Venue
Clinical Cancer Research
Published
2019-09-01
Volume
25
Issue
17
Pages
5376-5387
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2948496414
Cited by
234
References
10
FWCI
9.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-18-3590
The paper
Pasch, C. A., Favreau, P. F., Yueh, A. E., Babiarz, C. P., Gillette, A. A., Sharick, J. T., Karim, M. R., Nickel, K. P., DeZeeuw, A. K., Sprackling, C. M., Emmerich, P. B., DeStefanis, R. A., Pitera, R. T., Payne, S. N., Korkos, D. P., Clipson, L., Walsh, C. M., Miller, D., Carchman, E. H., . . . Deming, D. A. (2019). Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-18-3590

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.